Ulcerative colitis: open trials in Israel

• NCT06937086

  Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Assuta Ashdod Medical Center, Ashdod · Rambam Health Care Campus, Haifa · Edith Wolfson Medical Center, Holon · Shaare Zedek Medical Center, Jerusalem · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan · Sourasky Medical Center, Tel Aviv · Yitzhak Shamir Medical Center, Tsrifin

  Registry updated 2026-11-04

• NCT07415044

  LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  Trial Treatment · Phase 2 · Eli Lilly and Company

  Assuta Ashdod Medical Center, Ashdod · Barzilai Medical Center, Ashkelon · Rambam Health Care Campus, Haifa · Clalit Health Services - Lev Talpiot Clinic, Jerusalem · Meir Medical Center, Kfar Saba · Yitzhak Shamir Medical Center, Tsrifin

  Registry updated 2026-11-04

• NCT07483073

  A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  Trial Treatment · Phase 2 · Eli Lilly and Company

  Assuta Ashdod Medical Center, Ashdod · Rambam Health Care Campus, Haifa · Hadassah medical Center, Jerusalem · Shaare Zedek Medical Center, Jerusalem · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan · Yitzhak Shamir Medical Center, Tsrifin

  Registry updated 2026-11-04

• NCT06663332

  A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  Trial Treatment · Phase 3 · Janssen Research & Development, LLC

  Hadassah Ein-Qarem Medical Center, Jerusalem

  Registry updated 2026-11-03

• NCT07577856

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  Trial Treatment · Phase 3 · Janssen Research & Development, LLC

  Assuta Medical Center, Ashdod · Rambam Medical Center, Haifa · Bnai Zion Medical Center, Haifa · Wolfson Medical Center, Holon/Tel Aviv · Meir Medical Center, Kefar Sava · Galilee Medical Center, Nahariya · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan · Tel-Aviv Sourasky Medical Center, Tel Aviv · Shaare Zedek Medical Center, Yeruham

  Registry updated 2026-11-03

• NCT07012395

  A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.

  Beersheba · Beer Yaaqov · Haifa · Jerusalem · Jerusalem · Nahariya

  Registry updated 2026-10-27

• NCT07697456

  Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  Trial Treatment · Phase 2 · AbbVie

  Assuta Ashdod Medical Center /ID# 280535, Ashdod

  Registry updated 2026-10-27

• NCT07470879

  A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

  Trial Treatment · Phase 2 · Pfizer

  Rambam Health Care Campus, Haifa · Carmel Medical Center, Haifa · Hadassah medical Center, Jerusalem · Shaare Zedek Medical Center, Jerusalem · Sheba medical center, Ramat Gan · Kaplan Medical Center, Rehovot · Yitzhak Shamir Medical Center, Tsrifin

  Registry updated 2026-10-26

• NCT05076175

  A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  Trial Treatment · Phase 2/3 · Bristol-Myers Squibb

  Rambam Health Care Campus, Haifa · Shaare Zedek Medical Center, Jerusalem · Schneider Children's Medical Center, Petah Tikva

  Registry updated 2026-10-20

• NCT07185009

  A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  Trial Treatment · Phase 3 · Sanofi

  Jerusalem · Tel Aviv

  Registry updated 2026-10-16

• NCT04844606

  A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Soroka Medical Center, Beersheba · Rambam Health Care Campus, Haifa · Hadassah medical Center, Jerusalem · Shaare Zedek Medical Center, Jerusalem · Schneider Children's Medical Center, Petah Tikva · Yitzhak Shamir Medical Center, Tsrifin

  Registry updated 2026-10-07

• NCT07665294

  Combination CurQD and Vedolizumab in Ulcerative Colitis

  Trial Treatment · Phase 4 · Ryan C Ungaro

  Sheba medical center, Ramat Gan

  Registry updated 2026-10-05

• NCT07644117

  Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease

  Research · Shmuel Kivity, MD

  Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv

  Registry updated 2026-06-12

• NCT05442567

  A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  Trial Treatment · Phase 3 · Takeda

  Soroka University Medical Centre, Beersheba · Carmel Medical Center, Haifa · Rambam Health Care Campus PPDS, Haifa · Tel Aviv Sourasky Medical Center Ichilov - PPDS, Jerusalem · Hadassah Medical Center- Ein Kerem - PPDS, Jerusalem · Shaare Zedek Medical Center, Jerusalem · Schneider Childrens Medical Center of Israel Petah Tikvah PIN, Petah Tikva

  Registry updated 2026-05-07

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error